Jacob I. Stuckey

637 total citations
14 papers, 279 citations indexed

About

Jacob I. Stuckey is a scholar working on Molecular Biology, Genetics and Organic Chemistry. According to data from OpenAlex, Jacob I. Stuckey has authored 14 papers receiving a total of 279 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 4 papers in Genetics and 2 papers in Organic Chemistry. Recurrent topics in Jacob I. Stuckey's work include Epigenetics and DNA Methylation (8 papers), Genomics and Chromatin Dynamics (4 papers) and Genetics and Neurodevelopmental Disorders (3 papers). Jacob I. Stuckey is often cited by papers focused on Epigenetics and DNA Methylation (8 papers), Genomics and Chromatin Dynamics (4 papers) and Genetics and Neurodevelopmental Disorders (3 papers). Jacob I. Stuckey collaborates with scholars based in United States, Austria and Canada. Jacob I. Stuckey's co-authors include Stephen V. Frye, Lindsey I. James, Stephanie H. Cholensky, Dmitri Kireev, Kelsey N. Lamb, Jacqueline L. Norris, Jacqueline L. Norris‐Drouin, Jingkui Wang, Oliver Bell and Kenneth H. Pearce and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Jacob I. Stuckey

13 papers receiving 275 citations

Peers

Jacob I. Stuckey

ONCOL

GENET

Tyler Weaver United States

Tian Lu China

Bailin Shaw United States

Floriana De Bellis Italy

Katy Trent United States

Zhonglei Chen United States

Tara Hardy United Kingdom

Suzanna Bailey United States

Adrian Schomburg Germany

Adam Petrone United States

Tyler Weaver United States

Jacob I. Stuckey

230 ×0.9

17 ×0.5

34 ×1.2

ONCOL

12 ×0.5

GENET

14 ×1.0

Citations per year, relative to Jacob I. Stuckey Jacob I. Stuckey (= 1×) peers Tyler Weaver

Countries citing papers authored by Jacob I. Stuckey

Since Specialization

Citations

This map shows the geographic impact of Jacob I. Stuckey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacob I. Stuckey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacob I. Stuckey more than expected).

Fields of papers citing papers by Jacob I. Stuckey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacob I. Stuckey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacob I. Stuckey. The network helps show where Jacob I. Stuckey may publish in the future.

Co-authorship network of co-authors of Jacob I. Stuckey

This figure shows the co-authorship network connecting the top 25 collaborators of Jacob I. Stuckey. A scholar is included among the top collaborators of Jacob I. Stuckey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacob I. Stuckey. Jacob I. Stuckey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Stuckey, Jacob I., Jennifer A. Mertz, Jonathan E. Wilson, et al.. (2024). Abstract IA014: Mechanistic insights for the advancement of PPARG inverse agonists in muscle invasive urothelial cancer. Molecular Cancer Therapeutics. 23(12_Supplement). IA014–IA014. 1 indexed citations

Sims, Robert J., Jennifer A. Mertz, Jonathan E. Wilson, et al.. (2023). Abstract ND08: Discovery of FX-909, a first-in-class inverse agonist of the peroxisome proliferator-activated receptor gamma (PPARG) lineage transcription factor, to potentially treat patients with the luminal subtype of advanced urothelial cancer (UC). Cancer Research. 83(7_Supplement). ND08–ND08. 3 indexed citations

Stuckey, Jacob I., Nico Cantone, Alexandre Côté, et al.. (2021). Identification and characterization of second-generation EZH2 inhibitors with extended residence times and improved biological activity. Journal of Biological Chemistry. 296. 100349–100349. 9 indexed citations

Gardberg, A.S., Valérie Vivat, Lei Cui, et al.. (2021). 765 The first-in-class small molecule TREX1 inhibitor CPI-381 demonstrates type I IFN induction and sensitization of tumors to immune checkpoint blockade. SHILAP Revista de lepidopterología. A800–A800. 3 indexed citations

Gehling, Victor, John P. McGrath, Martin Duplessis, et al.. (2020). Design and Synthesis of Styrenylcyclopropylamine LSD1 Inhibitors. ACS Medicinal Chemistry Letters. 11(6). 1213–1220. 18 indexed citations

Côté, Alexandre, Shilpi Arora, Ludivine Moine, et al.. (2020). Design, Synthesis, and Pharmacological Evaluation of Second Generation EZH2 Inhibitors with Long Residence Time. ACS Medicinal Chemistry Letters. 11(6). 1205–1212. 27 indexed citations

Lamb, Kelsey N., Huitao Fan, Jacob I. Stuckey, et al.. (2019). Discovery and Characterization of a Cellular Potent Positive Allosteric Modulator of the Polycomb Repressive Complex 1 Chromodomain, CBX7. Cell chemical biology. 26(10). 1365–1379.e22. 42 indexed citations

Yelagandula, Ramesh, Carina Pribitzer, Jingkui Wang, et al.. (2019). Canonical PRC1 controls sequence-independent propagation of Polycomb-mediated gene silencing. Nature Communications. 10(1). 1931–1931. 56 indexed citations

Lamb, Kelsey N., Huitao Fan, Jacob I. Stuckey, et al.. (2019). Discovery and Characterization of a Cellularly Potent Positive Allosteric Modulator of the Polycomb Repressive Complex 1 Chromodomain, CBX7. SSRN Electronic Journal. 1 indexed citations

10.

Stuckey, Jacob I.. (2019). Design and Characterization of Chemical Probes Targeting the Chromodomains of Polycomb Repressive Complex I. Carolina Digital Repository (University of North Carolina at Chapel Hill).

11.

Watts, Brian, Jacob I. Stuckey, Jacqueline L. Norris‐Drouin, et al.. (2018). Quantitative Characterization of Bivalent Probes for a Dual Bromodomain Protein, Transcription Initiation Factor TFIID Subunit 1. Biochemistry. 57(14). 2140–2149. 17 indexed citations

12.

Norris‐Drouin, Jacqueline L., Stephanie H. Cholensky, Fengling Li, et al.. (2017). Discovery of Peptidomimetic Ligands of EED as Allosteric Inhibitors of PRC2. ACS Combinatorial Science. 19(3). 161–172. 39 indexed citations

13.

Lamb, Kelsey N., Jacob I. Stuckey, Jacqueline L. Norris, et al.. (2016). Chromodomain Ligand Optimization via Target-Class Directed Combinatorial Repurposing. ACS Chemical Biology. 11(9). 2475–2483. 38 indexed citations

14.

Stuckey, Jacob I., Catherine Simpson, Jacqueline L. Norris‐Drouin, et al.. (2016). Structure–Activity Relationships and Kinetic Studies of Peptidic Antagonists of CBX Chromodomains. Journal of Medicinal Chemistry. 59(19). 8913–8923. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact